Nystatin 100,000 Units/ml/Neomycin 0.35%/Polymyxin B 10,000 Units/ml/Triamcinolone 0.1% Otic Suspension is a compounded liquid medication. It is used to effectively treat conditions such as Otitis Externa, Swimmer's Ear, Acute Otitis Media, Chronic Otitis Media, and Malignant Otitis Externa.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Nystatin 100,000 Units/ml/Neomycin 0.35%/Polymyxin B 10,000 Units/ml/Triamcinolone 0.1% Otic Suspension is a specially compounded otic suspension designed to combat bacterial and fungal infections of the ear. This formulation is a homogeneous mixture of four potent active ingredients: Nystatin, Neomycin, Polymyxin B, and Triamcinolone, each playing a crucial role in the treatment process.
Nystatin, an antifungal agent, works by inhibiting the growth of fungi, effectively controlling fungal infections. Neomycin is an antibiotic that inhibits the growth of bacteria, helping to control bacterial infections. Polymyxin B, another antibiotic, works by killing bacteria, further enhancing the formulation's antibacterial properties. Triamcinolone, a corticosteroid, works by reducing inflammation, providing relief from the discomfort associated with these infections.
This formulation is specifically designed to treat various ear infections, including otitis externa, otitis media, and malignant otitis externa. It also effectively addresses symptoms such as itching, redness, and swelling of the ear caused by these infections. The uniform dispersion of the ingredients in a liquid medium ensures a consistent dose is delivered with each administration.
It is crucial to use this medication as directed by your healthcare provider to ensure its safety and effectiveness. If you have any questions or concerns about this formulation or its administration, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information and guidance to ensure optimal treatment outcomes.
This compounded formulation of Nystatin 100,000 Units/ml, Neomycin 0.35%, Polymyxin B 10,000 Units/ml, and Triamcinolone 0.1% Otic Suspension is a liquid dosage form designed for the treatment of otitis externa and bacterial and fungal infections of the external ear canal. The formulation is a homogeneous mixture, ensuring a uniform distribution of the active ingredients for effective administration.
The combination of Nystatin, an antifungal agent, Neomycin and Polymyxin B, both antibiotics, and Triamcinolone, a corticosteroid, provides a broad spectrum of activity against susceptible organisms. Nystatin works by inhibiting the growth of fungi, Neomycin and Polymyxin B work by inhibiting the growth of bacteria, and Triamcinolone works by reducing inflammation and swelling.
Patients with a known hypersensitivity to any of the components of the formulation or with a perforated tympanic membrane should not use this formulation. It is also advised that the formulation should not be used for longer than 7 days without consulting a healthcare provider. Patients should avoid contact with the eyes and avoid getting the medication in the eyes.
For any questions or concerns regarding the use of this formulation, patients are encouraged to reach out to their healthcare provider for further guidance and information.
Nystatin 100,000 Units/ml/Neomycin 0.35%/Polymyxin B 10,000 Units/ml/Triamcinolone 0.1% Otic Suspension is a compounded formulation that combines four potent ingredients to effectively treat bacterial and fungal infections of the ear. This includes conditions such as otitis externa, otitis media, and malignant otitis externa. In addition to treating the infection, this formulation also addresses inflammation and itching that often accompany these conditions.
The formulation contains Nystatin, an antifungal medication that halts the growth of fungi. Neomycin is an antibiotic that inhibits the growth of bacteria, while Polymyxin B is another antibiotic that works by killing bacteria. Triamcinolone, a corticosteroid, is included in the formulation to reduce inflammation and itching. Together, these ingredients provide a comprehensive treatment approach.
This formulation is intended for topical use only and should be applied to the affected area of the ear as directed by a healthcare professional. It is crucial to adhere to the instructions on the label and not to use more or less than the recommended amount. Additionally, this medication should not be used for a longer duration than prescribed.
If you have any questions or need further clarification about this formulation or its mechanism of action, please do not hesitate to reach out.
This is a compounded medication that contains four active ingredients: Nystatin, Neomycin, Polymyxin B, and Triamcinolone. It is in a liquid form that is designed to be administered into the ear.
This medication is typically used to treat ear infections. The combination of ingredients works to kill bacteria and fungi, and reduce inflammation.
This medication should be stored at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This medication is typically administered as drops into the ear. The exact dosage and frequency will be determined by your healthcare provider.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Use your next dose at the regular time. Do not double the dose to catch up.
Side effects may include ear discomfort or itching, temporary hearing loss, or a bad taste in your mouth. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist if you are allergic to neomycin, polymyxin B, or triamcinolone; or to other aminoglycoside antibiotics (such as gentamicin, tobramycin); or if you have any other allergies.
Before using this medication, tell your doctor or pharmacist if you are pregnant or planning to become pregnant, or if you are breastfeeding. The risks and benefits will need to be discussed with your healthcare provider.
Before using this medication, tell your doctor or pharmacist about all the products you use, including prescription drugs, nonprescription drugs, and herbal products. They can check for any potential interactions.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally